Skip to main content

Novozymes Value Stock - Dividend - Research Selection

Novozymes A/S

ISIN: DK0060336014, WKN: A1JP9Y

Market price date: 16.07.2021
Market price: 475,90 DKK




Novozymes A/S Fundamental data and company key figures of the share

Annual reports in DKK
Key figures 16-02-2021
Cash flow
Net operating cash flow 4.355.000.000
Capital Expenditures -940.000.000
Free cash flow 3.415.000.064
Balance sheet
Total Equity 11.233.000.000
Liabilities & Shareholders equity 20.510.000.000
Income statement
Net income 2.825.000.000
Eps (diluted) 10,020
Diluted shares outstanding 282.000.000
Net sales/revenue 14.012.000.000

Fundamental ratios calculated on: 16-07-2021

Ratios
Key figures 16-07-2021
Cash flow
P/C 30,82
   
P/FC 39,30
Balance sheet
ROI13,77
ROE54,77
Income statement
P/E47,50
Div. Yield0,00%
P/B11,95
P/S9,58


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolNZYM-B.CO
Market Capitalization19.009.306.624,00 USD
Country
IndicesNO INDEX
Sectors
Raw Data SourceIFRS in Millionen DKK
Stock Split2011-11-28,5.0000/1.0000
Internetwww.novozymes.com


Description of the company

Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. It operates through three divisions: Household Care and Technical Industries, Agriculture and Bioenergy, and Food and Beverages. The company offers solutions for the agriculture industry, including enzymes for animal nutrition to enhance digestion processes; probiotics; microbial solutions to maintain water quality that limits risk of disease and enhances yields in aquaculture; and microbial-based biocontrol and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; enzymes for drug delivery and drug formulation; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and biological wastewater treatment products. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.novozymes.com